Protalix BioTherapeutics, Inc. PLX NYSE

NYSE • Healthcare • Biotechnology • US • USD

Protalix BioTherapeutics, Inc. (PLX) has 20 已知的内部人和机构持有人记录. 最大持有人为 Sheratzki Eyal 持有 14,466,319 股. 其他重要持有人包括 Camber Capital Management LLC 和 FROST PHILLIP MD ET AL.

过去12个月，内部人进行了 14 笔交易，涉及 PLX 股票 — 11 笔买入 (价值为 $946.84K) 和 1 笔卖出 (价值为 $314.16). 内部人买入超过卖出，可能表明对公司前景有信心.

PLX 內部人持股

最大持股人

Sheratzki Eyal

14,466,319 股

买入（12个月）

$946.84K 价值

卖出（12个月）

$314.16 价值

12个月交易活动

买入 79%

卖出 7%

主要內部人持股

#	姓名	职位	持股数量	最近申报日期	相对规模
1	Sheratzki Eyal	10 Percent Owner	14,466,319	2007-01-05	100%
2	Camber Capital Management Llc	10 Percent Owner	10,775,000	2016-12-06	74%
3	Frost Phillip Md Et Al	10 Percent Owner	7,738,241	2009-09-11	53%
4	Marathon Investments Ltd.	10 Percent Owner	6,556,381	2007-01-10	45%
5	Toussia-cohen Sharon	10 Percent Owner	6,556,381	2007-01-05	45%
6	Techno-rov Holdings (1993) Ltd	10 Percent Owner	6,186,046	2007-01-05	43%
7	Akirov Alfred	Director	4,917,713	2013-08-16	34%
8	Dexcel Pharma Technologies Ltd.	10 Percent Owner	4,494,820	2021-06-03	31%
9	Hurvitz Eli	Director	1,616,100	2007-01-05	11%
10	Bio-cell Ltd	10 Percent Owner	1,509,948	2014-09-18	10%
11	Manor Moshe	President & CEO	1,300,000	2018-09-14	9%
12	Maimon Yossi	VP, Chief Financial Officer	700,000	2018-09-14	5%
13	Shaaltiel Yoseph	Executive VP, R&d	700,000	2018-09-14	5%
14	Rubin Eyal	Sr. VP and CFO	660,909	2024-11-05	5%
15	Aviezer David	President & CEO	418,000	2012-07-18	3%
16	Katz Iftah	VP of Operations	204,351	2007-06-13	1%
17	Almon Einat Brill	SVP, Chief Development Officer	196,995	2020-06-08	1%
18	Bashan Dror	President and CEO	188,516	2025-12-23	1%
19	Yanai Shlomo	Director	150,000	2014-07-24	1%
20	Palash Tzvi	Chief Operating Officer	125,000	2015-05-07	1%

近期交易 (过去12个月)

日期	姓名	职位	类型	股数	股价	总价值
2025-12-19	Bashan Dror	President and CEO	知情买入	56,000	$1.81	$101.36K
2025-11-18	Bar-shalev Amos	Director	知情卖出	168	$1.87	$314.16
2025-09-03	Elze Christian	Director	限制性股票授予 (RSU)	7,500	-	-
2025-09-03	Ben Zvi Shmuel	Director	限制性股票授予 (RSU)	7,500	-	-
2025-09-03	Forster Eliot	Director	限制性股票授予 (RSU)	7,500	-	-
2025-09-03	Bashan Dror	President and CEO	限制性股票授予 (RSU)	340,000	$1.64	$557.6K
2025-09-03	Naos Yaron	Sr. VP, Operations	限制性股票授予 (RSU)	50,000	$1.64	$82K
2025-09-03	Schwartz Aharon	Director	限制性股票授予 (RSU)	7,500	-	-
2025-09-03	Melincoff Gwen A	Director	限制性股票授予 (RSU)	7,500	-	-
2025-09-03	Boudes Pol F	Director	限制性股票授予 (RSU)	7,500	-	-
2025-09-03	Bar-shalev Amos	Director	限制性股票授予 (RSU)	7,500	-	-
2025-08-24	Mamlok Gilad	Sr. VP and CFO	未知	597,990	$1.45	$867.09K
2025-06-10	Schwartz Aharon	Director	知情买入	129,000	$1.60	$205.88K
2025-06-26	Elze Christian	Officer	未知	-	-	-